Physician profile
Lee Ellen Morrone
NPI 1255493664
$519.43
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $26.17 · 2021: $31.43 · 2022: $49.85 · 2023: $161 · 2024: $13.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $174.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $180.74 | 2019-2020 | |
| Astellas Pharma US INC | $160.99 | 2023 | |
| Vertical Pharmaceuticals, LLC | $37.43 | 2019 | |
| Scynexis, INC. | $32.43 | 2022 | |
| Therapeuticsmd, INC. | $29.61 | 2019-2021 | |
| Roche Diagnostics Corporation | $18.34 | 2019 | |
| Mayne Pharma Commercial LLC | $17.42 | 2022 | |
| Coopersurgical, INC. | $14.75 | 2020 | |
| Evofem Biosciences, INC. | $14.37 | 2021 | |
| Millicent US INC | $13.35 | 2024 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Morrone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.